PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för WZB-117. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

22 hits

Bibliografisk träff 2024-01-15

GLUT1 regulates the release of VEGF-A in the alveolar epithelium of lipopolysaccharide-induced acute lung injury.

Liang Y, Zhang H, Li J, Wang X, Xie J, Li Y, Li J, Qian Y, Zhang H, Wang T, Tang H, Chen X.

Cell Biol Int · journal article · DOI 10.1002/cbin.12127

Bibliografisk träff 2023-11-30

Upper glycolytic components contribute differently in controlling retinal vascular endothelial cellular behavior: Implications for endothelial-related retinal diseases.

Oska N, Eltanani S, Shawky M, Naghdi A, Gregory A, Yumnamcha T, Ibrahim AS.

PLoS One · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1371/journal.pone.0294909

Bibliografisk träff 2023-11-08

GLUT1 contributes to impaired epithelial tight junction in the late phase of acute lung injury.

Tang H, Chen Z, Gan S, Liang Y, Zhang H, Yang C, Lin L, Guo Y, Li S, Li J, Yao L.

Eur J Pharmacol · journal article · DOI 10.1016/j.ejphar.2023.176185

Bibliografisk träff 2023-10-15

The combination of pro-oxidative acting vanicosides and GLUT1 inhibitor (WZB117) exerts a synergistic cytotoxic effect against melanoma cells.

Nawrot-Hadzik I, Matkowski A, Fast M, Choromańska A.

Fitoterapia · journal article · DOI 10.1016/j.fitote.2023.105702

Bibliografisk träff 2023-08-04

A study of WZB117 as a competitive inhibitor of glucose transporter in high glucose treated PANC-1 cells by live-cell FTIR spectroscopy.

Poonprasartporn A, Xiao J, Chan KLA.

Talanta · journal article · DOI 10.1016/j.talanta.2023.125031

Bibliografisk träff 2023-04-25

Investigations into the Signaling Pathways Involving Glucose-Stimulated Zinc Secretion (GSZS) from Prostate Epithelial Cells In Vitro and In Vivo.

Parrott D, Suh EH, Khalighinejad P, Jordan VC, Arreola I, Lo ST, Sherry AD.

Mol Imaging Biol · research support, non-u.s. gov't; journal article; research support, n.i.h., extramural · DOI 10.1007/s11307-023-01821-w

Bibliografisk träff 2023-02-27

GLUT inhibitor WZB117 induces cytotoxicity with increased production of amyloid-beta peptide in SH-SY5Y cells preventable by beta-hydroxybutyrate: implications in Alzheimer's disease.

Chandan G, Ganguly U, Pal S, Singh S, Saini RV, Chakrabarti SS, Saini AK, Chakrabarti S.

Pharmacol Rep · journal article · DOI 10.1007/s43440-023-00466-4

Bibliografisk träff 2023-02-16

WZB117 Decorated Metformin-Carboxymethyl Chitosan Nanoparticles for Targeting Breast Cancer Metabolism.

De A, Wadhwani A, Sauraj, Roychowdhury P, Kang JH, Ko YT, Kuppusamy G.

Polymers (Basel) · research-article; journal article · DOI 10.3390/polym15040976

Bibliografisk träff 2022-09-16

WZB117 enhanced the anti-tumor effect of apatinib against melanoma via blocking STAT3/PKM2 axis.

Zhang RS, Li ZK, Liu J, Deng YT, Jiang Y.

Front Pharmacol · research-article; journal article · DOI 10.3389/fphar.2022.976117

Bibliografisk träff 2022-08-23

Impact of Comorbidities of Patients with Psoriasis on Phototherapy Responses.

Fatás-Lalana B, Cantón-Sandoval J, Rodríguez-Ruiz L, Corbalán-Vélez R, Martínez-Menchón T, Pérez-Oliva AB, Mulero V.

Int J Mol Sci · research-article; journal article · DOI 10.3390/ijms23179508

Bibliografisk träff 2022-06-09

Identification of a Subtype-Selective Allosteric Inhibitor of GluN1/GluN3 NMDA Receptors.

Zeng Y, Zheng Y, Zhang T, Ye F, Zhan L, Kou Z, Zhu S, Gao Z.

Front Pharmacol · research-article; journal article · DOI 10.3389/fphar.2022.888308

Bibliografisk träff 2021-03-01

Effect of Addition of WZB117 as an Inhibitor of Glucose Transporter 1 for Venous Blood Glucose Determination.

Zhang L, Ran Y, Zhu Y, Zhen Q.

Lab Med · journal article · DOI 10.1093/labmed/lmaa051

Bibliografisk träff 2021-02-04

Involvement of GLUT1 and GLUT3 in the growth of canine melanoma cells.

Suwabe Y, Nakano R, Namba S, Yachiku N, Kuji M, Sugimura M, Kitanaka N, Kitanaka T, Konno T, Sugiya H, Nakayama T.

PLoS One · research support, non-u.s. gov't; research-article; journal article · DOI 10.1371/journal.pone.0243859

Bibliografisk träff 2019-11-06

The Combination of MK-2206 and WZB117 Exerts a Synergistic Cytotoxic Effect Against Breast Cancer Cells.

Li YL, Weng HC, Hsu JL, Lin SW, Guh JH, Hsu LC.

Front Pharmacol · research-article; journal article · DOI 10.3389/fphar.2019.01311

Bibliografisk träff 2019-02-21

The Biguanides Metformin and Buformin in Combination with 2-Deoxy-glucose or WZB-117 Inhibit the Viability of Highly Resistant Human Lung Cancer Cells.

Yakisich JS, Azad N, Kaushik V, Iyer AKV.

Stem Cells Int · research-article; journal article · DOI 10.1155/2019/6254269

Bibliografisk träff 2018-08-02

Inhibition of GLUTs by WZB117 mediates apoptosis in blood-stage Plasmodium parasites by breaking redox balance.

Wei M, Lu L, Sui W, Liu Y, Shi X, Lv L.

Biochem Biophys Res Commun · journal article · DOI 10.1016/j.bbrc.2018.06.134

Bibliografisk träff 2018-06-11

Targeting glucose transport and the NAD pathway in tumor cells with STF-31: a re-evaluation.

Kraus D, Reckenbeil J, Veit N, Kuerpig S, Meisenheimer M, Beier I, Stark H, Winter J, Probstmeier R.

Cell Oncol (Dordr) · research-article; journal article · DOI 10.1007/s13402-018-0385-5

Bibliografisk träff 2018-05-29

Quercetin inhibits glucose transport by binding to an exofacial site on GLUT1.

Hamilton KE, Rekman JF, Gunnink LK, Busscher BM, Scott JL, Tidball AM, Stehouwer NR, Johnecheck GN, Looyenga BD, Louters LL.

Biochimie · research-article; journal article · DOI 10.1016/j.biochi.2018.05.012

Bibliografisk träff 2017-09-01

Blockade of GLUT1 by WZB117 resensitizes breast cancer cells to adriamycin.

Chen Q, Meng YQ, Xu XF, Gu J.

Anticancer Drugs · journal article · DOI 10.1097/cad.0000000000000529

Bibliografisk träff 2016-11-11

WZB117 (2-Fluoro-6-(m-hydroxybenzoyloxy) Phenyl m-Hydroxybenzoate) Inhibits GLUT1-mediated Sugar Transport by Binding Reversibly at the Exofacial Sugar Binding Site.

Ojelabi OA, Lloyd KP, Simon AH, De Zutter JK, Carruthers A.

J Biol Chem · research-article; journal article · DOI 10.1074/jbc.m116.759175

Bibliografisk träff 2016-03-24

Inhibition of Glut1 by WZB117 sensitizes radioresistant breast cancer cells to irradiation.

Zhao F, Ming J, Zhou Y, Fan L.

Cancer Chemother Pharmacol · journal article · DOI 10.1007/s00280-016-3007-9

Bibliografisk träff 2014-01-01

Overcoming 5-Fu resistance of colon cells through inhibition of Glut1 by the specific inhibitor WZB117.

Liu W, Fang Y, Wang XT, Liu J, Dan X, Sun LL.

Asian Pac J Cancer Prev · journal article · DOI 10.7314/apjcp.2014.15.17.7037